ScienceBioAge discontinues mid-stage trial of obesity drugadmin JATTVIBEDecember 7, 2024 by admin JATTVIBEDecember 7, 2024011 BioAge Labs said on Friday it is discontinuing its mid-stage trial studying its experimental drug as a monotherapy and in combination with Eli Lilly’s tirzepatide...